AstraZeneca and UNICEF Partner on Health and Air Quality in Thailand
What happened
AstraZeneca and UNICEF have partnered to address health challenges in Thailand. The collaboration is part of AstraZeneca's Young Health Programme, which has committed over US$100 million between 2010 and 2030. The initiative will focus on improving health literacy, preventing non-communicable diseases, and addressing health risks linked to air pollution through awareness, education, and school-based lung screening.
From bangkokpost.com
Why it matters
The partnership involves a significant health investment by AstraZeneca in Thailand. The program aims to strengthen policies and services that support children and young people’s health in the country.
From bangkokpost.com
Who's involved
- AstraZenecaProviding sustained commitment and investment through its Young Health Programme
- UNICEFExpanding its global partnership to address health challenges facing children and young people
- ThailandThe country where the partnership will implement programs focused on lung health and air pollution
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- ThailandSpeculative
Government health services in Thailand might see increased demand for lung screening and health education services.
Keep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Thailand
country in Southeast Asia
- Uganda's central bank addresses currency slump and remittance disruptions while attending international economic meetings in Thailand.
- The Tourism Authority of Thailand (TAT) is promoting Thailand through campaigns, led by Governor Thapanee Kiatphaibool, with Lisa serving as the Amazing Thailand Ambassador.
-
UNICEF
specialised agency of the United Nations
Related events
- Prudential plc and Mahidol University collaborated to examine the effects of climate change on health in Thailand.
- Laos and Thailand launched a joint action plan today to address transboundary haze pollution.
- Summit Therapeutics and AstraZeneca announced a partnership on July 4, 2025, to collaborate on lung cancer drug development.